Detection of MUM1/IRF4-IgH fusion in multiple myeloma

被引:56
|
作者
Yoshida, S
Nakazawa, N
Iida, S
Hayami, Y
Sato, S
Wakita, A
Shimizu, S
Taniwaki, M
Ueda, R
机构
[1] Nagoya City Univ, Sch Med, Dept Internal Med 2, Mizuho Ku, Nagoya, Aichi 4678601, Japan
[2] Kyoto Prefectural Univ Med, Dept Internal Med 3, Kyoto 602, Japan
[3] Shimane Prefectural Cent Hosp, Izumo, Shimane, Japan
关键词
MUM1/IRF4; multiple myeloma; t(6; 14)(p25; q32); IgH insertion; FISH; PFGE;
D O I
10.1038/sj.leu.2401563
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MUM1 (multiple myeloma oncogene 1)/IRF4 (interferon regulatory factor 4) gene has been identified as an oncogene transcriptionally activated by t(6;14)(p25;q32) chromosomal translocation in multiple myeloma (MFA). The significance of this alteration in MM remains unknown, as it is not detectable by means of conventional cytogenetic analysis. To address this issue, we established diagnostic procedures based on pulsed-field gel electrophoresis (PFGE) analysis and double color fluorescence in site hybridization (DCFISH) using DNA probes derived from the MUM1 and the immunoglobulin heavy chain (IgH) gene loci. Among a panel of 17 MM cell lines, three (17.6%) showed fusions between these two loci, which resulted in the juxtaposition of the MUM1 to the IgH 3' alpha-enhancer region by virtue of t(6;14) or insertion of the IgH sequences into the vicinity of the MUM1 gene and in the concomitant overexpression of the MUM1 mRNA. With similar results, fusions between MUM1 and IgH loci were observed by means of interphase DCFISH in eight (21.1%) out of the 38 MM cases, although no definite relationships between MUM1 status and specific clinical findings could be established.
引用
收藏
页码:1812 / 1816
页数:5
相关论文
共 50 条
  • [41] Prognostic Impact of MUM1/IRF4 Expression in Burkitt Lymphoma (BL): A Reappraisal of 89 BL Patients in Japan
    Satou, Akira
    Asano, Naoko
    Kato, Seiichi
    Elsayed, Ahmed Ali
    Nakamura, Naoya
    Ohshima, Koichi
    Nakamura, Shigeo
    BLOOD, 2015, 126 (23)
  • [42] IRF4/MUM1 expression is associated with poor survival outcomes in patients with peripheral T-cell lymphoma
    Heo, Mi Hwa
    Park, Ha Young
    Ko, Young Hyeh
    Kim, Won Seog
    Kim, Seok Jin
    JOURNAL OF CANCER, 2017, 8 (06): : 1018 - 1024
  • [43] Prognostic Impact of MUM1/IRF4 Expression in Burkitt Lymphoma (BL) A Reappraisal of 88 BL Patients in Japan
    Satou, Akira
    Asano, Naoko
    Kato, Seiichi
    Elsayed, Ahmed A.
    Nakamura, Naoya
    Miyoshi, Hiroaki
    Ohshima, Koichi
    Nakamura, Shigeo
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2017, 41 (03) : 389 - 395
  • [44] Frequent Igh Fusion Transcripts with Clinical Impact in Multiple Myeloma
    Cleynen, Alice
    Szalat, Raphael
    Samur, Mehmet Kemal
    Rashid, Naim
    Parmigiani, Giovanni
    Munshi, Nikhil C.
    Avet-Loiseau, Herve
    BLOOD, 2014, 124 (21)
  • [45] Copy Number Abnormalities Of The Interferon Regulatory Factor-4 (IRF4) Gene Are Associated With IRF4/MUM1 Expression In Peripheral T-Cell Lymphomas
    Boddicker, Rebecca L.
    Knudson, Ryan A.
    Ketterling, Rhett P.
    Mark, Law E.
    Xing, Xiaoming
    Cerhan, James R.
    Wu, Yanhong
    Cunningham, Julie M.
    Ansell, Stephen M.
    Feldman, Andrew L.
    BLOOD, 2013, 122 (21)
  • [46] MUM1/IRF4在恶性淋巴瘤中的表达及其意义
    陈愉
    蔡庆发
    赵彤
    吴炳绪
    陈美燕
    实用癌症杂志, 2006, (01) : 17 - 19
  • [47] IRF4 addiction in multiple myeloma
    Shaffer, Arthur L.
    Emre, N. C. Tolga
    Lamy, Laurence
    Ngo, Vu N.
    Wright, George
    Xiao, Wenming
    Powell, John
    Dave, Sandeep
    Yu, Xin
    Zhao, Hong
    Zeng, Yuxin
    Chen, Bangzheng
    Epstein, Joshua
    Staudt, Louis M.
    NATURE, 2008, 454 (7201) : 226 - 231
  • [48] IRF4 addiction in multiple myeloma
    Arthur L. Shaffer
    N. C. Tolga Emre
    Laurence Lamy
    Vu N. Ngo
    George Wright
    Wenming Xiao
    John Powell
    Sandeep Dave
    Xin Yu
    Hong Zhao
    Yuxin Zeng
    Bangzheng Chen
    Joshua Epstein
    Louis M. Staudt
    Nature, 2008, 454 : 226 - 231
  • [49] The significance of MUM1/IRF4 protein expression and IRF4 translocation of CD30(+) cutaneous T-cell lymphoproliferative disorders: A study of 53 cases
    Kiran, Tugce
    Demirkesen, Cuyan
    Eker, Candan
    Kumusoglu, Hakki
    Tuzuner, Nukhet
    LEUKEMIA RESEARCH, 2013, 37 (04) : 396 - 400
  • [50] 转录因子MUM1/IRF4在淋巴瘤中的作用机制研究进展
    马迪
    高春记
    解放军医学院学报, 2020, 41 (03) : 304 - 307